US equities
|
SPCX
$166.79
▲+4.93%
NVDA
$236.75
▲+1.20%
MU
$1,064.93
▼-0.93%
TSLA
$377.35
▲+1.82%
MSFT
$526.50
▲+1.73%
SNDK
$1,714.74
▼-0.31%
INTC
$117.21
▼-1.78%
META
$744.45
▲+2.25%
SPCX
$166.79
▲+4.93%
NVDA
$236.75
▲+1.20%
MU
$1,064.93
▼-0.93%
TSLA
$377.35
▲+1.82%
MSFT
$526.50
▲+1.73%
SNDK
$1,714.74
▼-0.31%
INTC
$117.21
▼-1.78%
META
$744.45
▲+2.25%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
GlycoMimetics, Inc. - Common Stock
(NQ:
GLYC
)
0.1570
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jun 13, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about GlycoMimetics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
GlycoMimetics to Report Second Quarter Financial Results on August 5, 2021
July 29, 2021
From
GlycoMimetics, Inc.
Via
Business Wire
Trial Launches to Evaluate GlycoMimetics’ Uproleselan Added to Cladribine Plus Low-Dose Cytarabine in AML Patients
July 22, 2021
From
GlycoMimetics, Inc.
Via
Business Wire
GlycoMimetics Announces Initiation of Clinical Trial Evaluating Uproleselan in Combination With Venetoclax and Azacitidine
July 12, 2021
From
GlycoMimetics, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
July 12, 2021
Gainers Celldex Therapeutics (NASDAQ:CLDX) stock rose 41.93% to $46.0 during Monday's pre-market session. The company's market cap stands at $1.8 billion. 180 Life...
Via
Benzinga
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
↗
May 01, 2021
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...
Via
Benzinga
The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street
↗
July 20, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 19) Cytokinetics, Incorporated...
Via
Benzinga
The Daily Biotech Pulse: Lilly, Morphic's Positive Data At ECCO, Humanigen's COVID Treatment Gets Expedited Review In UK, TransCode IPO
↗
July 09, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 8) Aerpio Pharmaceuticals, Inc...
Via
Benzinga
The Daily Biotech Pulse: Priority Review For Amgen's Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test
↗
July 08, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 7) Ambrx Biopharma Inc. (NYSE:...
Via
Benzinga
Topics
Product Recall
GlycoMimetics to Present at Jefferies 2021 Virtual Healthcare Conference
May 27, 2021
From
GlycoMimetics, Inc.
Via
Business Wire
GlycoMimetics Announces Investigator-Sponsored Phase 2 Clinical Trial Evaluating Uproleselan for Prevention of Gastro-Intestinal Toxicity in Autologous Hematopoietic Cell Transplantation
May 26, 2021
From
GlycoMimetics, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
May 13, 2021
Gainers MultiPlan (NYSE:MPLN) stock increased by 17.31% to $7.21 during Thursday's regular session. Trading volume for MultiPlan's stock is 4.0 million as of 12:30...
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
↗
May 04, 2021
On Tuesday morning, 58 companies hit new 52-week lows. Points of Interest: The largest company by market cap to set a new 52-week low was Lufax Holding (NYSE:LU)....
Via
Benzinga
The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron
↗
May 12, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ...
Via
Benzinga
The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings
↗
May 11, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10) AbbVie Inc. (NYSE: ABBV) -...
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
↗
May 10, 2021
Monday morning saw 78 companies set new 52-week lows. Intriguing Points: The largest company by market cap to set a new 52-week low was Rocket Companies (NYSE:RKT)....
Via
Benzinga
GlycoMimetics Inc (GLYC) Q1 2021 Earnings Call Transcript
↗
May 03, 2021
GLYC earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs
↗
May 07, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 6) GT Biopharma, Inc. (NASDAQ:...
Via
Benzinga
The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues
↗
May 05, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data
↗
May 04, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 3) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
GlycoMimetics Reports Highlights and Financial Results for First Quarter 2021
May 03, 2021
From
GlycoMimetics, Inc.
Via
Business Wire
GlycoMimetics to Report First Quarter Financial Results on May 3, 2021
April 26, 2021
From
GlycoMimetics, Inc.
Via
Business Wire
Positive Findings From Phase 1b Trial of GlycoMimetics’ GMI-1359 To Be Presented at AACR 2021 Meeting
April 10, 2021
From
GlycoMimetics, Inc.
Via
Business Wire
GlycoMimetics to Present at AACR 2021 Meeting on Positive Therapeutic Effects of GMI-1757 in a Pancreatic Adenocarcinoma Model
April 10, 2021
From
GlycoMimetics, Inc.
Via
Business Wire
Earnings Scheduled For May 3, 2021
↗
May 03, 2021
Companies Reporting Before The Bell • Scienjoy Holding (NASDAQ:SJ) is estimated to report quarterly earnings at $0.58 per share on revenue of $540.11 million. •...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
